Overview


According to FutureWise analysis the market for adaptive servo-ventilators (ASV) is expected to register a CAGR of 14.12% from 2023-2031.

Adaptive Servo-Ventilators devices are developed specifically to treat respiratory issues connected to sleep in which the brain fails to control breathing while sleeping. ASV for CSA efficiently treats central apneas and hypopneas by continually monitoring the patient's respiratory effort and adjusting the airflow pressure to preserve regular breathing patterns. Positive airway pressure therapy, such as CPAP or BiPAP, is used to treat obstructive sleep apnea (OSA) in patients who later develop central sleep apneas. This disease is known as complex sleep apnea syndrome (CompSAS). The goal of ASV for CompSAS is to provide adaptive support to deal with potential obstructive and central apneas during therapy.

According to the American Thoracic Society, ASV is a device that administers pressured air through tubing and a face mask, comparable to continuous positive airway pressure (CPAP), bi-level positive airway pressure (BPAP), and auto positive airway pressure (Auto-PAP). ASV is a more specialized device that analyzes your breathing patterns and adjusts the pressure applied to maintain stable breathing. Individuals who suffer from a medical condition known as central sleep apnea (CSA) benefit from using ASV. Individuals with primary CSA, systolic cardiac failure with Cheyne-Stokes breathing (CSB), and an ejection fraction (EF) under 45% are among them. Individuals suffer from obstructive sleep apnea and develop CSA when treated with CPAP, BPAP, or Auto-PAP, known as Complex or treatment-emergent CSA. Other causes of CSA include high altitude, transient arousal from sleep, and drug use.

FutureWise Market Research has published a report that provides an insightful analysis of Adaptive Servo-Ventilators Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the Adaptive Servo-Ventilators Market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Hamilton Medical
  • Getinge
  • Teijin
  • Philips
  • Draeger
  • Guangzhou Hypnus Healthcare Co
  • ResMed
  • ACUTRONIC Medical Systems AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Adaptive Servo-Ventilators Market:

  • In April 2021, Hamilton Medical launched upgraded version of HAMILTON-C1/T1-MR1. One of the most exciting new additions is Hamilton Medical’s unique ventilation mode INTELLiVENT-ASV, which is available on the HAMILTON-C1 and HAMILTON-T1 ventilators. INTELLiVENT-ASV is an advanced ventilation mode based on the Adaptive Support Ventilation (ASV) mode and acts as an assistant at the bedside. With this mode, the clinician sets target ranges for PetCO2 and SpO2, as well as limits for various controls. INTELLiVENT-ASV then adjusts the controls for CO2 elimination (%MinVol) and oxygenation (PEEP and Oxygen), and keeps the patient within the predefined ranges with minimal clinician interaction.

Sleep-related breathing conditions such central sleep apnea (CSA) and complex sleep apnea syndrome are on the rise. Obesity, aging populations, and changes in lifestyle have all been linked to the rising occurrence of these diseases. The need for ASV devices as a therapy option is driven by the expanding patient population. ASV technology is constantly evolving, leading to the development of ever-more sophisticated and efficient systems. Manufacturers have added new features, such as leak compensation, enhanced data collecting, and algorithms, in response to patients' changing breathing patterns. These technical developments have improved the effectiveness and patient comfort of ASV therapy, spurring market growth. Chronic respiratory diseases like congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are also treated with ASV devices. The potential market for ASV therapy is driven by its adaptability in treating various conditions. A prominent trend in healthcare is the increased emphasis on telemedicine, m-Health (mobile health), and artificial intelligence (AI). The combination of these technologies, which have been growing in popularity over time, has the potential to transform monitored and managed healthcare completely. These are the driving factors fuelling market growth. However, the high upfront cost of ASV devices can be a barrier, particularly in areas with limited healthcare facilities or for patients with restricted resources. The expense may prevent ASV therapy from being widely used. While there has been an increase in awareness of sleep-related breathing issues, patients and healthcare providers are still not sufficiently aware of ASV therapy as a therapeutic option. Limited knowledge and information about the advantages of ASV devices is one of the restraining factors responsible for limiting market growth.

By Control Type

  • Volume Triggered
  • Flow Triggered

By Application

  • Household
  • Hospital/Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasizes on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The CPAP Assistance Program (CAP) is an initiative aimed to make CPAP therapy more accessible to patients who might have financial difficulties or inadequate insurance coverage. In accordance with this initiative, a number of businesses, healthcare professionals, and manufacturers team up to deliver CPAP machines, masks, and supplies at a reduced price to eligible individuals in need. A wider patient population can benefit from CPAP therapy owing in large part to programs like CAP. More patients are able to get the necessary sleep apnea therapy if the cost of CPAP devices is reduced, which will enhance compliance rates and health outcomes. In North America, major medical device manufacturers such as Philips Respironics, and Fisher & Paykel Healthcare that specialize in sleep apnea products have had success commercializing their products contributing to the region's dominance in the market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Adaptive Servo-Ventilators (ASV) Market By Control Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Adaptive Servo-Ventilators (ASV) Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Adaptive Servo-Ventilators (ASV) Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Adaptive Servo-Ventilators (ASV) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Adaptive Servo-Ventilators (ASV) Market, By Control Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Volume Triggered
        2. Flow Triggered

  • 8.   Adaptive Servo-Ventilators (ASV) Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Household
        2. Hospital/Clinics
        3. Others

  • 9.   North America Adaptive Servo-Ventilators (ASV) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Adaptive Servo-Ventilators (ASV) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Adaptive Servo-Ventilators (ASV) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Adaptive Servo-Ventilators (ASV) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Hamilton Medical
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Getinge
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Teijin
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Philips
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Draeger
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Guangzhou Hypnus Healthcare Co
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. ResMed
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. ACUTRONIC Medical Systems AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients